Everest Medicines (HKEX 1952.HK) announced the closing of its previously announced exclusive licensing and collaboration agreement with Travere Therapeutics, Inc. (NASDAQ: TVTX) for the...
Siloam International Hospitals has again been recognised at the highest level with two of its hospitals receiving Magnet® with Distinction Recognition. Siloam Hospitals Kebon Jeruk became...
Introducing the New Intelligent Hydration Innovation "Hydra" and Exclusive Signature Treatments from Swiss Cellular Cosmetics
SPA InterContinental, a landmark destination for luxury wellness and premium...
Avantor, a leading global provider of mission-critical products and services to the life sciences and advanced technology industries,announced today it has been appointed the...
On June 25, CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the "MCV4", trade name:...
June 26, 2026, Everest Medicines today announced that China’s National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL(R) (lerodalcibep), a...
